Basket

Record was added to the basket

1.Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial / Novak P. ... [et al.] . The Lancet. Neurology . - Vol. 16, no. 2 (2017), s. 123–134 [Dokument nie je vo fonde knižnice]
From the basket
Citation
Bookmark

Selected documents
Citation

citace PRO
article

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.